# Aurinia Pharmaceuticals Inc.: Form DEF 14A, filed Apr 17, 2025

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: DEF 14A
- Filed: 2025-04-17
- Accepted by EDGAR: Apr 17, 2025, 16:02 ET
- Period: 2025-05-15
- Accession: 0001600620-25-000032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000160062025000032/auph-20250415.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000160062025000032/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000160062025000032/auph-20250415.htm

Filed Apr 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001600620-25-000032. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.